Cancer: Resistance to radiation
Nature Communications
April 18, 2012
A method for tracking cancer cells that survive radiation treatment in mice is reported in a study published in Nature Communications this week. These findings permit the study of the surviving cells in mice and may aid in the treatment of the resistant cells.
Solid tumours are known to have areas in their centre that have a low oxygen supply - hypoxia - and this has been associated with the resistance to radiation treatment. Hiroshi Harada and colleagues tag cells based on the presence or absence of a transcription factor HIF1alpha that has been associated with hypoxic tissues. They identify cancer cells that are resistant to radiation treatment in mice and show that these surviving cells are initially negative for HIF1alpha but later acquire high levels of this protein. They also show that these cells move towards blood vessels in the surviving tumour.
Their findings reveal more information about the molecular features of the cells that are resistant to radiation and suggest that targeting cells that express HIF1alpha may be an appropriate strategy for treating radiation resistant cancer.
doi: 10.1038/ncomms1786
Research highlights
-
Jan 13
Genetics: Correcting for genetic associations between alcohol and diseaseNature Communications
-
Dec 23
Biomedical engineering: Tiny device goes with the (blood) flowNature Communications
-
Dec 21
Epidemiology: Underdetection of COVID-19 after the first lockdown in FranceNature
-
Dec 18
Geology: Alpine summits may have been ice-free during life of Tyrolean IcemanScientific Reports
-
Dec 17
Epidemiology: Mapping gaps in measles vaccination coverageNature
-
Dec 17
Neuroscience: When you’re smiling, the whole world smiles with youNature
